Our home: 225 Warren Street, Newark, NJ
Education: weekly lectures and graduate teaching
No research can be conducted without support
The ICPH building, inside and out
Our scientists: engaged in multidisciplinary studies
Welcome to PHRI
As today’s biomedical advances occur at a dizzying pace, the Public Health Research Institute, a center of the Institute for Infectious & Inflammatory Diseases (i3D) at New Jersey Medical School, pursues its research mission to help eliminate the infectious diseases spreading across the planet.
Founded in 1942 in New York City by legendary Mayor Fiorello LaGuardia, PHRI has been home to seminal discoveries in biomedical sciences. Hosted in the ICPH building in Newark, NJ, since 2002, PHRI became part of the New Jersey Medical School in 2006 and joined Rutgers University in 2013.
For almost 80 years, PHRI has fostered a culture of international talent, a collaborative environment, and the mentoring of young scientists. Today, PHRI remains committed to the pursuit of excellence in research and learning.
PHRI NEWS & EVENTS
04-21-23 Dr. Marcela Rodriguez published her study to identify dynamin-like proteins, which are required factors for the production of extracellular vesicles in M. tuberculosis in the current issue of EMBO Reports. To download this open access article, visit www.embopress.org
04-18-23 Samantha Avina, PhD student in the laboratory of Dr. Chaoyang Xue at PHRI was interviewed for the American Society for Microbiology to share her research and education experience. To read her story, visit www.asm.org
WORLD TB DAY, 24 March, commemorates the announcement in 1882 when Dr. Robert Koch discovered the Mycobacterium tuberculosis, the bacilli that causes tuberculosis (TB). This date is an opportunity to highlight research on TB prevention and control and educate the public about the worldwide impact of TB. In 2021, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide. Six million men, 3.4 million women and 1.2 million children – progress against TB was lost during the Covid-19 epidemic, with TB control worsening in many countries impact by Covid-19 (WHO, Oct 2022). TB is present in all countries and age groups. But TB is curable and preventable.
On this occasion we announce the ongoing efforts of the TB Regional Prospective Observational Research Tuberculosis (TB-RePORT) Consortium, supported by the US National Institute of Allergy and Infectious Diseases (NIAID) and bilateral funding from host countries – some supported since 2013. This consortium across 8 countries (Brazil, China, India, Indonesia, Philippines, S Africa, S Korea and Uganda), representing approximately 70% of the world’s TB epidemic, establishes a platform for future combined or comparative studies between bench science and clinical research that has been highly productive in national and international research aims helping with control and prevention.
Rutgers University is the ongoing Coordinating Center for this Consortium, having this central coordination effort since 2020, now ongoing till 2028. Please visit reportinternational.org for detailed information about these ongoing efforts to better control and eradicate tuberculosis worldwide.
For faculty, postdoctoral and staff opportunities at PHRI, visit Open Positions.
Welcome to PHRI
As today’s biomedical advances occur at a dizzying pace, the Public Health Research Institute pursues its research mission to help eliminate the infectious diseases spreading across the planet.
Founded in 1942 in New York City by legendary Mayor Fiorello LaGuardia, PHRI has been home to seminal discoveries in biomedical sciences. Hosted in the ICPH building in Newark, NJ, since 2002, PHRI became part of the New Jersey Medical School in 2006 and joined Rutgers University in 2013.
For almost 80 years, PHRI has fostered a culture of international talent, a collaborative environment, and the mentoring of young scientists. Today, PHRI remains committed to the pursuit of excellence in research and learning.